“…In addition, the radiomic logistic regression model could noninvasively predict the likelihood of malignancy of breast lesions amenable to breast biopsy. Although in the medical literature many studies are devoted to assessing the possibility of differentiating between benign and malignant lesions for MRI data [ 7 , 8 , 9 , 10 , 11 , 12 , 13 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 ], there are currently no public and widely accepted radiomics-based guidelines for the pre-operative prediction of malignancy likelihood in patients amenable to MR-VABB. Some recent studies have paved the way to a radiomics-driven exploratory research phase [ 33 , 34 ], and much effort should be made to realize translation into clinical settings.…”